Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001661471 | SCV001879411 | pathogenic | not provided | 2021-04-13 | criteria provided, single submitter | clinical testing | This variant is expected to result in the loss of a functional protein. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. |
Institute of Human Genetics, |
RCV004783978 | SCV005397114 | pathogenic | Polycystic kidney disease, adult type | 2024-10-30 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PS4_MOD,PM2 |
Fulgent Genetics, |
RCV004783978 | SCV005640697 | pathogenic | Polycystic kidney disease, adult type | 2024-05-17 | criteria provided, single submitter | clinical testing | |
Laboratory of Gastroenterology and Hepatology, |
RCV001844992 | SCV001876925 | pathogenic | Autosomal dominant polycystic kidney disease | 2021-09-01 | no assertion criteria provided | research |